DAFTAR PUSTAKA
Afshari, JT, Ghomian, N, Shameli, A, Shakeri, MT, Fahmidehkar, MA, Mahajer, E, et al. 2005.Determination of interleukin-6 and tumor necrosis factor-alphaconcentrations in iranian-khorasanian patients with preeclampsia, BMC Pregnancy and Childbirth, 5:14.
Agarwal, I & Karumanchi, SA 2011, Preeclampsia and the antiangiogenic state,Pregnancy Hypertens, 1 : 17-21.
Ahmed, A 2011, New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications.Thromb Res.;127(Suppl 3):S72–75.
Alice, W, Sarosh, R,Ananth,SK 2009, Preeclampsia: The Role of Angiogenic Factors in Its Pathogenesis. Physiology. Volume 24. June.
Alicia,MV, Pellicer, B, Marín, AP, and Pellicer, A 2014,Relationship between Maternal Immunological Response during Pregnancy and Onset of Preeclampsia. Journal of Immunology Research Volume, Article ID 210241, 15 pages.
Altman, D, Carroli, G, Duley, L, Farrell, B, Moodley, J, Neilson, J, et al. 2002. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate?, The Magpie Trial: a randomised placebo-controlled trial, Lancet, 359(9321):1877–90.
Askie, LM, Duley, L, Henderson-Smart, DJ, Stewart, LA 2007, Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet, 369(9575):1791-1798.
Austgulen, R, Lien, E, Vince, G1997,Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in preeclampsia, European Journal of Obstetrics & Gynecology and Reproductive Biology, 71:53-58.
Aydin, S, Benian, A, Madazali, R 2004, Plasma malondialdehyde, superoxide dismutase, se-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia, European Journal of Obstetrics & Gynecology and Reproductive Biology, 113:21-25. Baviera, G, D’Anna, R, Corrado, F, Ruello, A, Buemi, M, Jasonni, VM.
2002,ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR, Vol 47:3.
Bhargava, I 2001,Rubella-a comprenhensive perspective, Pregnancy At Risk Current Concepts, 4ed. 78-88.
Bhattacharya, M, Raut, V 2001, Management of pregnancy induced hypertension, Pregnancy at Risk Current Concepts, 4ed. 263-267. Birawa, AD, Hadisaputra, H, Hadijono, S 2009, Kadar D-dimer pada ibu
hamil dengan preeklamsia berat dan normotensi di RSUP Dr. Kariadi, Majalah Obstetri dan Ginekologi Indonesia, Vol 33.(2):65-78.
non-invasive assessment, Journal of the American Heart Association 5:724-726.
Bohn, T 2008, Dietary factors influencing magnesium absorption in humans, Current Nutrition & Food Science, 4(1):53-72.
Borok, Z, Weitz, J, Owen, J 1984, Fibrinogen proteolysis and platelet granule release in preeclampsia/eclampsia, Blood 63(3):525-531. Budak, E, Madazli, R, Aksu, MF 1998, Vascular cell adhesion molecule-1
(VCAM-1) and leukocyte activation in pre-eclampsia and eclampsia, International Journal of Gynecology & Obstetric, 63:115-121.
Buhimschi, IA, George, RS, Kristof, C & Robert, EG 1998, The nitric oxide pathway in pre-eclampsia:pathophysiological implications,human reproduction update, European Society for Human Reproduction and Embryology, Vol. 4, No. 1 pp. 25–42.
Caroline, H, Stella, L 2010, Magnesium and exercise, critical reviews in food science and nutrition, 42:6, 533-563
Carty, DM, Delles, C, Dominiczak, AF 2010, Preeclampsia and future maternal health, J Hypertens, 28:1349–1355.
Chaiworapongsa, T, Romero, R, Yoshimatsu, J 2002, Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia, J Matern Fetal Neonatal Med, 12(1):19-27.
Chappell, LC, Seed, PT, Briley, A, Kelly, FJ, Hunt, BJ, Charnock-Jones, DS, Mallet, A& Poston, L 2002, A longitudinal study of biochemical variables in women at risk of preeclampsia, Am J Obstet Gynecol, 187,127–136.
Chappell, LC, Seed, PT, Kelly, FJ, Briley, A, Hunt, BJ, Charnock-Jones, DS, Mallet, A & Poston, L 2002, Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function, Am J Obstet Gynecol,187,777-784.
Chavarria, ME, Gonzalez, LL, Paleta, YG 2008, Adhesion molecules changes at 20 gestation weeks in pregnancies complicated by preeclampsia, European Journal of Obstetrics & Gynecology and Reproductive Biology, 137:157-164.
Chesley, L 1978, Hypertensive disorder in pregnancy first edition.
Chothia, C, Jones, EY1997, The molecular structure of cell adhesion molecules,Annu. Rev. Biochem, 66:823–62.
Clarke, SD, Piercy CN 2010, Pre-eclampsia and HELLP syndrome, JPOG, Vol 36(3):125-131.
Connolly, E, Worthley, LI 1999, Intravenous magnesium: critical care and resuscitation, l: 162-172.
Creasy, RK 1994, Preterm labor and delivery, maternal fetal medicine, 3rded, 494:513.
Cuningham, Leveno, Bloom 2010, Pregnancy hypertension, Williams Obstetrics 23rd ed, 706-748, 2010
Daniel, Y, Geva, E&Eshed-Englender, T 2000, Vascular cell adhesion molecule-1 in normal, failed and ectopic pregnancy, Am J Reprod Immunol, 43(2):92-7.
Dasgupta, S, Sarkhel, A, Jain, A 2015, Single loading dose of magnesium sulphate in severe preeclampsia and eclampsia-is it effective? A randomized prospective study, Obstet Gynecol Int J 2(6): 00059. De, Vries, JI, Van, Pampus, MG, Hague, WM, Bezemer, PD, Joosten, JH
2012, Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT, J Thromb Haemost, 10(1):64-72.
DeLemos, J, Hennekens C & Ridker, P 2000, Plasma Concentration of Soluble Vascular Cell Adhesion Molecule-1 and Subsequent Cardiovascular Risk, J Am Coll Cardiol, 36:423-426.
Derzsy, Z, Prohaszka, Z, Rigo, J, Jr, Fust, G, Molvarec, A 2011, Activation of the complement system in normal pregnancy and preeclampsia, Mol Immunol, 47:1500–1506.
Desideri, G, Marinucci, M & Tomassoni G 2002, Vitamin E supplementation reduces plasma vascular cell adhesion molecule-1 and von willebrand factor levels and increases nitric oxide concentrations in hypercholesterolemic patients, J Clin Endocrinology & Metabolism, 87(6):2940-2945.
Dharma, R, Wibowo, N, Raranta, HPT 2005, Disfungsi endotel pada preeklampsia. makara, kesehatan, Vol. 9, No. 2: 63-69
Duley, L 2009, The global impact of pre-eclampsia and eclampsia, Semin Perinatol, 33:130–137.
Endresen, MJR, Morris, JM, Nobrega, AC, Buckley, D, Linton, EA, Redman, CW 1998, Serum from preeclamptic women induces vascular cell adhesion molecule-1 expression on human endothelial cells in vitro: a possible role of increased circulating levels of free fatty acids, Am J Obstet Gynecol, 179(3 Pt 1):665-70.
Ertekin, AA , Kapudere, B, Eken, MK, Ilhan, G, Dirman, S, Sargin, MA, et al. 2015, Does aggressive and expectant management of severe preeclampsia affect the neurologic development of the infant?, Int J Clin Exp Med, 8(10):19325-19331 www.ijcem.com /ISSN:1940-5901/IJCEM0013074.
Farzadnia, M, Ayatollahi, H, Hasan-zade, M, Sadeghian, MH, Meybodi, NT 2009, Serum level of vascular cell adhesion molecule-1 (sVCAM-1) in sera of normal and preeclamptic pregnancies, Acta Medica Iranica, 47(1)65-70.
Fawcett, WJ, Haxby EJ & Male DA 1998,Magnesium: physiology and pharmacology: Review Article, Bri. J Anaesth, 83(2): 302-20.
Garcia, GG, Arevalo, G, Schiraldi, R & Sebastian, DJ 2012, Maternal and neonatal complications of severe preeclampsia: preliminary prospective study: 11ap4‐11, Eur J Anesthesiol, 29(1): 171-2.
Girsang, E 2004, Analisa tekanan darah dan proteinuria sebagai faktor prognosa. kematianmaternal dan perinatal pada preeclampsia berat dan eklampsia. Tesis bagian obgyn FK USU RUP H. Adam Malik/ RSUD dr. Pirngadi Medan.
Glass, RH & Golbus, MS 1994, Recurrent abortion, Maternal Fetal Medicine, 3ed, 445:451.
Goynumer, G, Yucel, N, Adali, E, Tan, T, Baskent, E & Karadag, C 2012, Vascular risk in women with a history of severe preeclampsia, Journal of Clinical Ultrasound, Vol 41, Issue 3, pages 145–150, Gupta, S, Aziz, N, Sekhon, L, Agarwal, R, Mansour, G, Li, J, et al. 2009,
Lipid peroxidation and antioxidant status in preeclampsia a systematic review, Obs Gyn Survey, 64(11): 750-3.
Gunawan, H 2010, Peranan antioksidan untuk mencegah preeklamsiaa, Mini Referat Feto Maternal FK USU.
Gurtner, GC, Davis, V, Li H, McCoy, MJ, Sharpe, A, Cybulsky, MI 1995, Targeted dirsruption of the murine VCAM-11 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation, Gnes & Dev, 9:1-14.
Haddad, B, Barton, JR, Livingston, JC, Chahine, R, Sibai, BM 2000, HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome versus severe preeclampsia: onset at < or=28.0 weeks’ gestation, Am J Obstet Gynecol, 183:1475–1479.
Haeger, M, Unander, M, Bengtsson, A 1991, Complement activation in relation to development of preeclampsia, Obstet Gynecol, 78:46– 49.
Haller, H, Ziegler, EM, Homuth, V, Drab, M, Eichhorn, J, Nagy, Z, et al. 1997, Endothelial adhesion molecules and leukocyte integrins in preeclamptic patients. Hypertension, 29(1 Pt 2):291-6.
Han, X, He, J, wang, A & Dong, M 2014, Serum Follistatin-like-3 was elevated in second trimester of pregnant women who subsequently developed preeclampsia, Hypertension in Pregnancy, Cross Mark, 277-282.
Henke, Vanessa, G, Bateman, Brian ,T, Leffert, Lisa, R 2013, Spinal Anesthesia in Severe Preeclampsia, Official Journal Of The International Anesthesia Research Society, Volume 117 - Issue 3 - p 686–693.
Heyl, W, Handt, S, Reister, F, Gehlen, J, Mittermayer, C, Rath, W 1999, The role of soluble adhesion molecules in evaluating endothelial cell activation in preeclampsia, Am J Obstet Gynecol, 180(1 Pt 1), 68-72.
Hidayat, AS 2010, Peningkatan ekspresi protein bax plasenta meningkatkan resiko preeklamsia, Majalah Obstetri dan Ginekologi Indonesia, Vol 33(1).
pre-eclampsia, gestational hypertension, and normal pregnancy: evidence of selective dysregulation of vascular cell adhesion molecule-1 homeostasis in pre-eclampsia, Am J Obstet Gynecol, 179:464-469.
Himpunan Kedokteran Fetomaternal Indonesia, 2010 Panduan penatalaksanaan kasus obstetri.
Hofmeyr, GJ, Atallah, AN & Duley, L 2007 Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems (Review). Cochrane; 4: 1-20.
Hosking, BM, Wang, SCM, Downes, M, Koopman, P, Muscat, GE 2004, The VCAM-1 gene that encodes the vascular cell adhesion molecule is a target of the sry-related high mobility group box gene, Sox18, J Biological Chemistry Vol 279(7), 5314-5322.
Hubbard, AK, Rothlein, R 2000, Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades, Free Radic Biol Med 28,1379-1386.
Hubel, CA 1999, Oxidative stress in the pathogenesis of preeclampsia. P.S.E.B.M, Vol 222.
Hupperts, B 2008,Placental Origins of Preeclampsia,Challenging the Current Hypothesis. Hypertension,51:970-975; originally published online February 7, 2008; Available at :http://hyper.ahajournals.org/content/51/4/970.
Integrin, a4b1 2007, (VLA-4) and Vascular Cell Adhesion Molecule 1 (VCAM-1) Enhances Migration of Human Melanoma Cells Across Activated Endothelial Cell Layers. J Cell Physiol, 212: 368-374. Kahn, SR, Platt, R, McNamara, H 2009, Inherited thrombophilia and
preeclampsia within a multicenter cohort: the montreal preeclampsia study. Am J Obstet & Gynecol Vol 200(2), 151-153. Kashinakunti, SV, Sunitha, H, Gurupadappa, K, Shankarprasad, DS,
Suryaprakash, G & Ingin, JB 2010, Lipid Peroxidation and Antioxidant Status in Preeclampsia, Al Ameen J Med Sci, 3(1): 38-41.
Kelly, KA, Allport, JR, Yu, AM, Sinh, S, Sage, EH, Gerszten, RE, Weissleder, R 2007, SPARC is a VCAM-1 counter-ligand that mediates leukocyte transmigration, J Leukoc Biol 81: 748-756. Keman, K, Prasetyorini, N, Langgar, MJ 2009, Perbandingan ekspresi
p53, Bel-2, dan indeks apoptosis trofoblas pada preeklamsia/eklampsia dan kehamilan normal, Majalah Obstetri dan Ginekologi Indonesia Vol 33(3),151-159.
Klemke, M, Weschenfelder, T, Konstandin, MH & Samstag, Y, High Affinity Interaction of
Koh, SCL, Anandakumar, C, Biswas, A 1999, Coagulation an fibrinolysis in viable mid-trimester pregnancies of normal, intrauterine growth retardation, chromosomal anomalies and hydrops fetalis and their eventual obstetric outcome, J Perinta Med 27, 458-464.
Koh, SCL, Ratnam, SS 1989, Haemostatic trends in normal pregnancy in Chinese women, J Obstet & Gynecol 9,271-276.
Koh, SCL, Viegas, OAC, Yuen, R 1992, Plasminogen activators and inhibitors in normal late pregnancy, postpartum and in the postnatal period, Int J Gynecol Obstet 38:9-18.
Krauss, T, Azab, H, Dietrich, M, Augustin, HG 1998, Fetal plasma levels of circulating endothelial cell adhesion molecules in normal and preeclamptic pregnancies, european journal obstetrics gynecology reproductive biology, 78(1), 41-5.
Krauss, T, Emons, G, Kuhn, W 2002, Predictive value of routine circulating soluble endothelial cell adhesion molecule measurements during pregnancy, Clin Chem, 48(9),1418-25.
Krauss, T, Kuhn W, Lakoma, C 1997, Circulating endothelial cell adhesion molecules as dignostic markers for the early identification of pregnant women at risk for devlopment of preeclampsia, Am J Obstet Gynecol 177(2),443-9.
Kusuma, TW, Affandi, B, Ocviyanti, D 2009, Manajemen resiko dalam pelayanan pasien preeklamsiaa berat eklampsia di Instalasi Gawat Darurat RSUPNCM. Majalah Obstetri dan Ginekologi Indonesia Vol 33(3):135-142.
Lam, C, Lim, KH, Karumanchi, SA 2005, Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia, Hypertension;46:1077–1085
Lana, KW 2004. Diagnosis and management of preeclampsia, American Family Physician December 15, Volume 70, Number 12.
Laurent, D, Jean, CG 2003, The therapeutic use of magnesium in anesthesiology,intensive care and emergency medicine. Can. J. Anesth, 50(7):732-46.
Ledingham, MA, Thomson, AJ, Jordan, F, Young, A, Crawford, M, Norman, JE 2006, Cell adehsion molecule expression in the cervix and myometrium during pregnancy and parturition, AJH 19:235-242.
Leduc, L, Wheeler, JM, Kirshon, B, Mitchell, P, Cotton, DB 1987, Coagulation profile in severe preeclampsia, Am j Obstet & Gynecol 157:331-336.
Leif, M, Goran, B, Jan, E, Ekerfeltb, C, Jonssonb, Y, and Sharmac, S 2005. Immunology of Preeclampsia. Chem Immunol Allergy. Basel, Karger, vol 89, pp 49–61.
Lia, X.L, Chena, T.T, Donga , X, Goua, W.L, Laub, S, Stoneb, P, Chen, Q 2014, Early onset preeclampsia in subsequent pregnancies correlates with early onset preeclampsia in first pregnancy, European Journal of Obstetrics & Gynecology and Reproductive Biology Vol 177, Pages 94–99.
Lyall, F & Greer, LA 1996, The vascular endothelium in normal pregnancy and pre-eclampsia, Review Reproductive, 1: 107-16.
Lynch, AM, Murphy, JR, Byers, T, Gibbs, RS, Neville, MC, Giclas, PC, Salmon, JE, Holers VM 2008, Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia, Am J Obstet Gynecol, 198:385, e1–9.
Majed, BH & Khalil, A 2012, Ecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn, Pharmacological reviews, 64(3): 540-5.
Manurung, RT, Wiknjosastro, G 2009, Mortalitas maternal pada preeklamsia berat dan eklampsia di rumah sakit umum pusat dr. cipto mnagunkusumo tahun 2003-2005 dan faktor-faktor yang mempengaruhinya, Majalah Obstetri dan Ginekologi Indonesia Vol 33(1),33-41.
Marca, B, 2012, Endothelial dysfunction; an important mediator in the pathophysiology of hypertension during preeclampsia, Minerva Ginecol, 64(4): 309-320.
Marui, N, Offermann, MK, Swerlick, R, Kunsch, C, Rosen, CA, Ahmad, M, et al. 1999, Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells, J Clin Invest 92(4),1866-74.
Marx, N, Sukhova, GK, Collins, T, Libby, P, Plutzky, J 1999, PPAR activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. J Am Heart Association 99,3125-3131.
Mayet, WJ, Schwarting, A, Orth, T, Duchmann, KH, Buschenfelde, MZ 1996, Antibodies to proteinase 3 mediate expression of vascular cell adhesion molecule-1 (VCAM-1), Clin Exp Immunol 103(2):259-67.
McMaster, MT, Zhou, Y, Fisher, SJ 2004, Abnormal placentation and the syndrome of preeclampsi, Semin Nephrol, 24:540–547.
Mehta, A 2001, Mehta A: Toxoplasma in pregnancy, Pregnancy at risk current concepts 4ed 73-77.
Mellembakken, JR, Aukrust, P, Hestdal, Ueland, T, Abyholm, T, Videm, V 2001, Chemokines and leukocyte activtion in the fetal circulating during preeclampsia, J Am Heart Association 38,394-398.
Mellembakken, JR, Hogasen, K, Mollnes, TE, Hack, CE, Abyholm, T, Videm, V 2001, Increased systemic activation of neutrophils but not complement in preeclampsia, Obstet Gynecol, 97:371–374.
Michelle, H, Ananth,SK&Richard, L 2007,Pathophysiology of the Clinical Manifestations of Preeclampsia. Clin J Am Soc Nephrol 2: 543-549. Montagnoli, C, Larciprete, G, 2014, Preeclampsia: definitions, screening
tools and diagnostic criteria in the supersonic era. World J ObstetGynecol; 3(3): 98-108.
Nabil, E, Gioia T 2011, Electrolyte disorders and arrhythmogenesis, Cardiology Journal, Vol. 18, No. 3, pp. 233–245.
identifies inflammatory activation of cells in atherosclerosis. J Am Heart Association.
Neish, AS, Williams, AJ, Palmer, HJ, Whitley, MZ, Collins, T 1992, Functional analysis of the human vascular cell adhesion molecule 1 promoter, J Exp Med 176(6),1583–1593.
Ngowa, JDK, Kasia, JM, Alima, J, Domgue, JF, Ngassam, A, Bogne, JB & Mba, S 2015, Maternal and perinatal complications of severe preeclampsia in three referralHospitals in Yaoundé, Cameroon, Open Journal of Obstetrics and Gynecology, 5, 723-730.
Ogle, R, Hyett, J 2005, Screening for spontaneous preterm labor and delivery,High risk pregnancy 3ed Vol 2:1293-1303.
Osborn, L, Hession, C, Tizzard, R, Vassallo, C, Luhowskyj, S, Chi-Rosso, G, et al. 1989, Direct Expression Cloning of Vascular Cell Adhesion Molecule 1, a Cytokine-induced Endothelial Protein that Binds to Lymphocytes. Cellpress 1989;59(6):1203-11.
Parulekar, SV, Parulekar, RS 2001, Pregnancy induced hypertension: Current concepts, Pregnancy at risk current concepts 4ed 257-262. Pekonen, F, Rasi, V, Ammala, M, Viinikka, L, Ylikorkala, O 1986, Platelet
function and coagulation in normal and preeclamptic pregnancy. Thromb Res 43(5):553-60.
Penn, Z 2005, Breech presentation, High risk pregnancy 3ed Vol 2:1334-1358.
Petla, LT, Chikkala, R, Ratnakar, KS, Kodati, V & Sritharan, V 2013, Biomarkers for the management of pre-eclampsia in pregnant women, Indian J Med Res 2013; 138: 60-67.
Phocas, I, Rizos, D, Papoulias, J, Xyni, K, Sarandkou, A, Salamalekis, E 2000, A comparative study of serum soluble vascular cell adheison molecule-1 and soluble intercellular adhesion molecule-1 in preeclampsia. Journal of Perinatology 2:114-119.
Portelinha, A, Belo, L, Tejera, E, et al. 2008, Adhesion molecules (VCAM-1 and ICAM-(VCAM-1) and C-reactive protein in women with history of preeclampsia. Acta Obstetrics et Gynecologica. Acta Obstetricia et Gynecologica Scandinavica Vol 87(9) 969–971.
Pratama, G, Wibowo, N, Surjana, EJ, Subakir, SB, Setiabudy, RD 2009, Peningkatan kadar soluble Vasculer Cell Adhesion Molecule-1 (sVCAM-1) sebagai petanda aktivasi endotel pada serum penderita sindrom antifosfolipid yang dipajankan pada kultur endotel tali pusat manusia, Majalah Obstetri dan Ginekologi Indonesia Vol. 33(1):35-39.
Rahajuningsih, D, Noroyono, W, Hessyani, PTR 2005, Disfungsi endotel pada preeklamsia, majalah kesehatan nusantara, Kesehatan, Vol. 9, No. 2: 63-69.
Ratih, D, Hadisaputra, H, Kritanto, H 2009, Hubungan kadar albumin urin dengan berat badan lahir bayi pada preeklamsia berat, Majalah Obstetri dan Ginekologi Indonesia Vol. 33(1):8-19.
Raynor, BD, Parthasarathy, S 1997, Maternal serum vascular cell adhesion molecule concentration during pregnancy, J Soc Gynecol Investig 4(2):78-80.
Resnik, R 1994 Post-term pregnancy, Maternal fetal medicine 3ed 521-526.
Robert, JM 1994, Pregnancy-related hypertension. Maternal fetal medicine 3ed 804-843.
Robert, JM 1999, Objective evidence of endothelial dysfunction in preeclampsia, Am J Kidney Dis 33(5):992-7.
Roberts, JM, Cooper DW 2001, Pathogenesis and genetics of preeclampsia, Lancet, 357:53–56.
Roberts, JM, Pearson, G, Cutler, J & Lindheimer, M 2003, Summary of the nhlbi working group on research on hypertension during pregnancy, Hypertension, 41, 437-445.
Roeshadi, RH 2006, Upaya menurunkan angka kesakitan dan angka kematian ibu pada penderita preeklmapsia dan eklampsia.
Royal College of Obstetrics and Gynaecologists, 2005, Thromboprophylaxis during pregnancy, labour and after vaginal delivery, Clin Appl Thrombosis/Hemostasis 11(4):467-473.
Sacks, FM, Campos, H 2010, Dietary therapy in hypertension, N Engl Journal of Medicine, Vol 362(22):2102-2112.
Saleh, AA, Bottoms, SF, Welch, RA, Preeclampsia, delivery, and the hemostatic system.
Sattar, N, Ramsay, J, Crawford, L 2003, Classic and novel risk factor parameters in women with a history of preeclampsia. J Am Heart Association, 42:39-42.
Seely, T, Solomon, CG 2003, Insulin resistance and its potential role in pregnancy-induced hypertension, J Clin Endocrinol Metab, 88: 2393-2398.
Shah, S, Vadera, V 2001, Maternal infections-a laboratory review. Pregnancy at risk current consepts, 4ed, 108-114.
Sibai, BM, Romero, R, Klebanoff, MA 2009, Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia, Am J Obstet & Gyneco, Vol 200(6):630-632.
Sibai, BM, Stella, CL 2009, Diagnosis and management of atypical preeclampsia-eclampsia, Am J Obstet & Gyneco Vol 200(5):481-483.
Soeatmadji, DW 2000, Pemeriksaan-pemeriksaan untuk deteksi difungsi endotelial. Forum Diagnosticum, No 4.
Sowinski, KM 2000, Endothelial function an fysfunction. American College of Clinical Pharmacy.
Stirling, Y, Woolf, L, North, WR, Seghatchian, MJ, Meade TW 1984, Haemostasis in normal pregnancy. Thromb Haemost, 52(2):176-82. Strevens, H, Wide-Swensson, D, Hansen, A, Horn, T, Ingemarsson, I,
Larsen, S, et al. 2003, Glomerular endotheliosis in normal pregnancy and pre-eclampsia, Br J Obstet Gynaecol 110:831-836. Svedas, E, Nisell, H, VanWijk, MJ, Nikas, Y, Kublickiene, KR 2002,
Endothelial dysfunction in uterine circulation in preeclampsia: can estrogens improve it?, Am J Obstet Gynecol 187(6):1608-16.
Tanjung, MT, Siddik, HD, Hariman, H, KOH SC 2005,Coagulation andfibrinolysis in preeclampsia and neonates, Clin Appl Thromb Hemost; 11(4):467-73.
Uzan, J, Carbonnel, M, Piconne, O, Asmar, R, Ayoubi, JM 2011,Preeclampsia: pathophysiology, diagnosis, and management, Vasc Health Risk Management; 7: 467-474.
Vadachkoria, S, Sanchez, SE, Qiu, C 2004, Hyperhomocysteinemia and elevated soluble vascular cell adhesion molecule-1 concentrations are associated with an increased risk of preeclampsia, Gynecol Obstet Invest 58:133-139.
Vadachkoria, S, Woelk, GB, Mahomed, K 2006,Elevated soluble vascular cell adhesion molecule-1 elevated homocysteinemia, and hypertriglyceridemia in relation to preeclampsia risk, Am J of hypertension Vol 19(3):235-242.
Van,BJD, Kanters, E, Hordijk, PL 2007,Endothelial signaling by ig-like cell adhesion molecules. Arterioscler Thromb Vasc Biol 27: 1870-1876. Van, Rijn, BB, Hoeks, LB, Bots, ML, Franx,A, Bruinse, HW 2006,
Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol, 195(3):723-728.
Van, JWJ, Ubachs, JMH 1991, Blood coagulation and fibrinolysis during normal pregnancy, Eur J Clin Chem Clin Biochem 29(1):45-50, Walfisch, A, Hallak, M 2005,Hypertension. high risk pregnancy 3ed Vol
2:772-789.
Walker, JJ 2000, Preeclampsia, Lancet.;356:1260 –1265.
Whitley, GS, Cartwright, JE 2010, Cellular and molecular regulation of spiral artery remodelling: lessons from the cardiovascular field, Placenta; 31(6): 465-474.
Wiknjosastro 2010, Buku panduan praktis pelayanan kesehatan maternal dan neonatal, Edisi 1, Cet. 12, Jakarta : Bina Pustaka.
Wilhelm, J, Markus, K 2012, Magnesium basics, Clin Kidney J, 5[Suppl 1]: i3–i14.
Witko, SV, Descamps,LB 1994,Neutrophil-derived oxidants and proteinases as immunomodulatory mediators in inflammation. Mediar Inflamm; 3: 257=273.
Wittchen, E 2009,Endothelial signaling in paracellular and transcellular leukocyte transmigration. Frontier Bioscience; 14: 2522-2545.
Yulinti, T 2008, Faktor-faktor angiogenik sebagai prediktor preeklamsia. Forum Diagnosticum No 6.
Yurkovetsky, Z, Skates, S, Lomakin, A 2010, Development of a multimarker assay for early detection of ovarian cancer, J. Clin. Oncol. 28(13), 2159–2166.
Yvonne, J 2005, Cytokines and immune balance in preeclampsia, Linköping University Medical Dissertations No. 924 Yvonne Jonsson.
Zhou, SJ, Yelland, L, McPhee, AJ, Quinlivan, J, Gibson, RA, Makrides, M 2012, Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia, Am J Clin Nutr; 95(6): 1378-84.
